Reset filter
Nyckelord
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
    1. 7.1. Anestesi
    1. 7.2. Dermatologi
    1. 7.3. HNO
    1. 7.4. Geriatrik
    1. 7.5. Gynekologi och obstetrik
    1. 7.6. Invärtes medicin
      1. Hematologi
      1. Infektionssjukdomar
      1. Kardiologi och angiologi
      1. Pneumologi
      1. Gastroenterologi
      1. Nefrologi
      1. Endokrinologi och ämnesomsättning
      1. Reumatologi
    1. 7.7. Neurologi
    1. 7.8. Oftalmologi
    1. 7.9. Palliativ medicin
    1. 7.10. Patologi och rättsmedicin
    1. 7.11. Pediatrik
    1. 7.12. Psykiatri och psykosomatik
    1. 7.13. Radiologi
    1. 7.14. Kirurgi
      1. Allmänkirurgi och bukkirurgi
      1. Neurokirurgi
      1. Plastikkirurgi
      1. Hjärt- och thoraxkirurgi
      1. Akutkirurgi och ortopedi
      1. Kärlkirurgi
    1. 7.15. Urologi
    1. 7.16. Odontologi samt mun-, käk och ansiktskirurgi
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

2291 Sökresultat.
Relevans Bedömning Nya först Gamla först

Pathology - Colon and Rectum Carcinoma - Anatomic Pathology Form - 2019345v2.31 - Colon and Rectum Carcinoma - Anatomic Pathology Form

- 2015-01-08 - 1 Formulär, 4 Item-grupper, 65 Dataelement, 1 Språk
Item-grupper: COLORECTAL: CRF HEADER , COLORECTAL PATHOLOGY: FORM ADMINISTRATION, PATHOLOGY: SURGICAL PATHOLOGY - MACROSCOPIC/GROSS DESCRIPTION, PATHOLOGY: SURGICAL PATHOLOGY - MICROSCOPIC DESCRIPTION
Colon and Rectum Carcinoma - Anatomic Pathology Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=99CD59C5-A97A-3FA4-E034-080020C9C0E0

Eligibility Postoperative Ileus NCT02510911

- 2019-06-14 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?; ODM derived from: https://clinicaltrials.gov/show/NCT02510911

Eligibility Colon Cancer NCT00819780

- 2017-12-20 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00819780

Eligibility Colon Cancer NCT01003600

- 2017-12-20 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information; ODM derived from: https://clinicaltrials.gov/show/NCT01003600

Eligibility Colon Cancer NCT00890188

- 2017-12-20 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00890188

Eligibility Colon Cancer NCT00411450

- 2017-02-10 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00411450

Eligibility Liver Metastasis NCT00068068

- 2016-10-08 - 1 Formulär, 2 Item-grupper, 21 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00068068

Eligibility Colon Cancer NCT01239095

- 2019-01-15 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection; ODM derived from: https://clinicaltrials.gov/show/NCT01239095

Eligibility Colon Cancer NCT00193167

- 2016-08-03 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193167

Eligibility Colon Cancer NCT00695201

- 2016-01-10 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00695201

dbGaP phs001003 Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets - pht010322.v2.p1

- 2023-11-06 - 6 Formulär, 1 Item-grupp, 2 Dataelement, 1 Språk
Item-grupp: pht010322
Principal Investigator: Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Colonic Neoplasms,Ovarian Neoplasms,Stomach Neoplasms,Cholangiocarcinoma,Pancreatic Neoplasms,Rectal Neoplasms,Esophageal Neoplasms,Colorectal Neoplasms,Endometrial Neoplasms,Paraneoplastic Syndromes, Ocular https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001003 Recent advances and insights into the molecular pathogenesis of cancer have led to the development of novel molecular and biologic targeted therapies for the treatment of advanced cancer patients. A critical challenge in extending these studies involves the identification and validation of new therapeutic targets for future cancer therapies. In this study, we performed whole exome and RNA-Seq analysis metastases to determine the nature and frequency of somatic mutations.

pht010323.v2.p1

1 Item-grupp 2 Dataelement

pht010324.v2.p1

1 Item-grupp 4 Dataelement

pht010325.v1.p1

1 Item-grupp 2 Dataelement

pht010326.v2.p1

1 Item-grupp 5 Dataelement

Eligibility

1 Item-grupp 9 Dataelement

Eligibility Liver Cirrhosis NCT02508623

- 2019-04-27 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices; ODM derived from: https://clinicaltrials.gov/show/NCT02508623

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial